| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Azelastine hydrochloride |
Is a |
False |
Azelastine (substance) |
Inferred relationship |
Some |
|
| Product containing azelastine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Azelastine adverse reaction |
Causative agent |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to azelastine |
Causative agent |
False |
Azelastine (substance) |
Inferred relationship |
Some |
|
| oftalmisk form af azelastin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Azelastine (substance) |
Inferred relationship |
Some |
|
| Azelastine-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to azelastine |
Causative agent |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Azelastine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
|
| Product containing azelastine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only azelastine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Azelastine only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only azelastine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Product containing azelastine and fluticasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Azelastine and fluticasone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Azelastine and fluticasone only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
| Azelastine- and fluticasone-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Azelastine (substance) |
Inferred relationship |
Some |
1 |
FHIR